Exchange: NASDAQ·Updated 07:38 PM EDT
GRI logo

GRIGRI Bio Inc

$1.87
$0.09
(5.06%)
Today
Closed $1.87
$0.0592
(3.17%)
After Hours
Mkt Cap$3.31M
Vol39,134.00
News
all
press releases
News Placeholder
GRI Bio Reports Positive Study Results For Chronic Lung Disease, But Stock Slumps 20% — What Happened?
The company said that the new data indicate that GRI-0621 may support the regeneration of lung tissue.
Stocktwits
News Placeholder
GRI Bio Drug Shows Promising Lung Function Recovery In Patients With Thickened Lungs
GRI Bio shared promising data from a Phase 2a trial for idiopathic pulmonary fibrosis, a chronic lung disease with no known cause.read more...
Benzinga
News Placeholder
Barclays lifts Kojamo, I-RES ratings; cuts Grainger on low yield
investing.com
<
...
1
>